BioRestorative shareholders approve doubling of stock incentive plan shares to 6.85M

BioRestorative Therapies, Inc.

Class I director Nickolay Kukekov re-elected with 2,050,111 votes for, 135,114 withheld, 2,048,738 broker non-votes.
Amendment to 2021 Stock Incentive Plan approved: 1,647,022 for, 518,921 against, 19,282 abstentions, 2,048,738 broker non-votes. Authorized shares increased from 3,850,000 to 6,850,000.
Marcum LLP ratified as auditor for FY2024: 4,152,145 for, 18,696 against, 63,122 abstentions.
Annual meeting held September 19, 2024; all three proposals passed.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.